Novartis: Dementia trials
The registry lists 14 Dementia studies with Novartis as lead sponsor. 0 are open to participants now and 5 have results posted.
Phase 1 1Phase 2 2Phase 3 8Phase 4 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Study of the Efficacy and Safety of Various Anti-inflammatory Agents in Participants With Mild Cognitive Impairment or Mild Alzheimer's DiseaseTerminatedNCT04795466Phase 2Results posted
- A 24-Week Efficacy, Safety and Tolerability of Rivastigmine Patch Study in Patients With Probable Alzheimer's DiseaseCompletedNCT01399125Phase 3Results posted
- Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44CompletedNCT00948766Phase 4Results posted
- Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD)CompletedNCT00623103Phase 3Results posted
- Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's DiseaseCompletedNCT00428389Phase 3Results posted
- A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's DiseaseActive, not recruitingNCT07094516Phase 2
- Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease ParticipantsActive, not recruitingNCT05469360Phase 1
- Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's DiseaseCompletedNCT00305903Phase 4
- An Open-label Extension to Evaluate the Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's DiseaseCompletedNCT00219232Phase 3
- Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive ImpairmentTerminatedNCT00134953Phase 3
- Rivastigmine Capsules in Patients With Probable Vascular DementiaCompletedNCT00130338Phase 3
- Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's DiseaseCompletedNCT00104442Phase 4
- Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's DiseaseCompletedNCT00099242Phase 3
- Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular DementiaCompletedNCT00099216Phase 3